Goldman Leslie J. 4

4 · NORTHWEST BIOTHERAPEUTICS INC · Filed Jul 2, 2020

Insider Transaction Report

Form 4
Period: 2020-07-02
Goldman Leslie J.
Senior Vice President
Transactions
  • Award

    Options to purchase Common Stock, par value $0.001

    2020-07-02+21,822,93721,822,937 total
    Exercise: $0.25From: 2020-12-01Exp: 2030-12-01Common Stock, par value $0.001 (21,822,937 underlying)
Footnotes (1)
  • [F1]These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.

Documents

1 file
  • 4
    tm2022243d11_4.xmlPrimary

    OWNERSHIP DOCUMENT